⌘K

Login Start Free

Home/Filings/4/0001209191-23-016330

4//SEC Filing

Dasu Badri N 4

Accession 0001209191-23-016330

CIK 0001427925other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:45 PM ET

Size

4.8 KB

Accession

0001209191-23-016330

Insider Transaction Report

Form 4

Period: 2023-03-03

ACELRX PHARMACEUTICALS INCACRX

Chief Engineering Officer

Transactions

Tax Payment
Common Stock
2023-03-03$1.31/sh−398$521→ 18,771 total

Footnotes (1)

[F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ACELRX PHARMACEUTICALS INC

CIK 0001427925

Entity typeother

Related Parties

1

filerCIK 0001310803

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 4:45 PM ET
Size: 4.8 KB

View on SEC.gov